Background
==========

Female urinary incontinence (FUI) is a major health problem and has a significant detrimental impact quality of life \[[@B1]\]. Feelings of low self-esteem, embarrassment and helplessness are common\[[@B2]\]. Between 20-50% of women suffer from incontinence at some time in their lives \[[@B3],[@B4]\], and the prevalence of symptoms and demand for services is rising substantially \[[@B5]\]. Pelvic floor exercises delivered in an individual consultation with a physiotherapist are effective in the management of stress-related and urge female urinary incontinence \[[@B6]-[@B8]\]. Some physiotherapists advocate the use of group treatments to deliver these treatments, the hypothetical benefits being increased peer-support, mutual self-help, giving and sharing of information, reduction in depression and isolation, increased motivation and compliance with treatment\[[@B9]\]. A large randomised controlled trial (RCT) from the Netherlands showed no difference in the physical responses to treatment between individual and group sessions, but did not consider quality of life, acceptability or cost \[[@B10]\]. If effectiveness can be demonstrated across a range of physical and health related quality of life outcomes, the group approach is potentially more cost-effective, provided that other important components of resource use are not increased, and women are not deterred from attending treatment. The aim of this study was to undertake an appraisal of the acceptability, clinical effectiveness and relative costs of group versus individual treatment sessions in the management of female urinary incontinence. The study used a mixed methods approach, integrating quantitative and qualitative approaches alongside a prospective cost analysis. The qualitative study is reported in an accompanying paper.

Methods
=======

Aims
----

To (i) compare effectiveness in terms of symptoms, quality of life, and costs. (ii) Determine patient preference for group or individual physiotherapy sessions for the management of female urinary incontinence and the association between patient preference and outcome.

Participants and eligibility
----------------------------

Inclusion criteria were (i) women aged 18 years and over; (ii) able and willing to give informed written consent with an interpreter if necessary; (iii) clinical symptoms of stress and/or urge incontinence. Exclusion criteria were (i) pregnancy; (ii) recent pelvic surgery (less than three months); (iii) history of pelvic malignancy; (iv) current urinary infection; (v) grade III and IV prolapse; (vi) disease of the central nervous system (e.g. multiple sclerosis, cerebrovascular accident) or acute mental illness and dementia; (vi) previous physiotherapy for incontinence within the last 12 months.

Women were recruited from primary and secondary care referrals made to physiotherapy departments of five medium to large sized National Health Service (NHS) trusts in England, UK (detailed at the end of the paper). The study had the approval of Local Research Ethics Committees and written consent was obtained from all participants.

Outcome measures
----------------

Assessments were made prior to treatment (baseline), and then at 6 weeks and 5 months after randomisation. The primary outcomes were the Symptom Severity Index (SSI), with scores ranging from 0 (no severity) to 20 (maximum severity) \[[@B11]\] and the Incontinence-related Quality of Life (IQOL) questionnaire, with scores ranging from 0 (very poor) to 100 (excellent) \[[@B12]\]. The SSI focuses on the physical symptoms of urinary incontinence, and IQOL focuses on the psychological and distress aspects of the condition. Secondary outcomes consisted of health service costs incurred in the follow up period, out of pocket expenses and costs incurred by patients. In addition, patients were asked to rate their perception of response to treatment on a 10-point rating of benefit (from no benefit to maximum benefit). Follow-up data were collected by postal questionnaire.

Preference
----------

Elicitation of preference was independent of randomisation, and was collected at the time the women were invited to participate in the trial. Women were asked, if they could choose, whether their preference was treatment in a group setting, on an individual basis or no preference.

Intervention
------------

### Group treatment

The treatment comprised three one-hour long sessions over a three-week period. Group sizes were anticipated to be approximately 10 women. The first session included an explanation of normal bladder function, causes of stress incontinence, teaching and practice of pelvic floor exercises. The second session included causes of urge incontinence, principles of bladder training, discussion and motivation, practice and progression of pelvic floor exercise including exercises to target fast and slow twitch fibres, with a variation of starting positions. The third session included a bladder quiz to re-enforce knowledge, avoidance of aggravating factors, repetition of pelvic floor exercises, discussion and motivation and safe lifting. Women received an individual assessment prior to the groups, including a pelvic floor examination if indicated. Details of the treatment are available at <http://www2.warwick.ac.uk/fac/med/research/ctu/trials/ecr/bladders>.

### Individual treatment

All participants received an assessment using the same protocol as the group session, followed by any of the techniques used in the group sessions, taught on a one to one basis. A maximum of three sessions of one-hour duration was permissible, reflecting the duration of the group sessions. Additional treatments, including electrotherapy, vaginal cones and biofeedback were not included in either treatment protocol.

Randomisation and blinding
--------------------------

Randomisation was in a ratio of 2:1 (group: individual) to facilitate regular group sessions, and minimise waiting for treatment. Researchers involved with data collection, entry and analysis, were blind to the treatment delivered to each participant. It was not possible to blind the participants or the clinical collaborators delivering the treatment. The allocation sequence was random (computer generated). Allocations were coded and transferred to brown, sealed, sequentially numbered envelopes. The sequential entry of participants was carefully monitored during quality control checks.

Statistical analysis
--------------------

### Sample size

The sample size was estimated a priori, assuming a power of 90% and a significance level of 0.05 to detect a minimally clinically important difference between the groups of 2 points (standard deviation 3.16) on the SSI scale. Allowing for a 20% withdrawal and dropout rate, a minimum sample size of a total of 140 patients was required\[[@B13]\]. No correction was needed for the imbalanced randomisation\[[@B13]\].

### Statistical and economic analysis

All statistical and economic analyses were intention to treat and statistical significance was claimed at p \< 0.05. Baseline characteristics were compared for those who completed the trial and the non-completers. To address potential biases due to incomplete data, two analyses were computed (a) complete case analysis (CCA) and (b) replacing missing observations using multiple imputation\[[@B14]\], combined to give one inference using the rules of Little and Rubin \[[@B15]\]. The imputation dataset was used for sensitivity analysis and produced very similar results to the complete case analysis. The complete case analysis has been reported in this paper. The distributions of the data were checked to ensure parametric assumptions were met. Continuous and categorical data were summarised as mean and standard deviation at each time point. Analysis of covariance was used to assess the treatment effects adjusted for age, baseline value and preference for treatment at baseline. For categorical data, logistic regression was used. A simple economic appraisal was conducted alongside the trial. Cost data were collected by self-completed questionnaire to determine direct costs (i.e. those incurred by the patient, NHS or private healthcare system) and major components of productivity loss (i.e. days of absence from usual occupation). Healthcare costs included in and out-patient hospital appointments and admissions (nurse, consultant or other), visits to the GP, medicines and pads on prescription, personal expenditure on medicines, pads, complementary therapies, and other hygiene products. Unit costs for health care were taken from Department of Health reference costs which were available in 2005 \[[@B16]\]. All costs were standardised to the NHS financial year 2004/2005 which was when the cost-analysis was completed. Costs of days off work were based on average wages in 2004. Owing to the relatively short time frame of the study, discounting was not applied. As the economic analysis was by intention to treat, the cost estimates for group treatment includes the costs associated with providing individual treatments in who were randomised to group treatment but received individual treatment. The costs of non-attendance were included in the analysis using intention to treat principles.

Results
=======

Participant flow and characteristics
------------------------------------

The flow of participants through the study (consort statement) is given in Figure [1](#F1){ref-type="fig"}. Between February 2003 and March 2004, 174 eligible women were randomised (111 to group and 63 to individual therapy arms) and 91% (158/174) of women completed the trial. Seven women (4%), all of who were in the group treatment arm, withdrew during the trial - either because of illness (n = 5) or delays in being offered a treatment slot (n = 2). Near equal numbers of women were lost to follow up in each arm (6/111 group treatment; 3/63 in individual treatment). Twenty-eight women in the group therapy sessions received individual as opposed to group sessions. The primary reason for this was the timing of the sessions. Participant characteristics are shown in Table [1](#T1){ref-type="table"}, and were well matched in the two arms of the trial. There were no statistically or clinically significant differences between women who completed the trial and those who did not. The number of non-responders between the five referrals centres was borderline significant at 6 weeks (p = 0.041).

![**Consort diagram**.](1472-6874-9-26-1){#F1}

###### 

Baseline assessments for each treatment arm

  -------------------------------------------------------------------------------------------------------------
                                                                  ***Group***\      ***Individual (n = 63)***
                                                                  ***(n = 111)***   
  ----------------------------------------------- --------------- ----------------- ---------------------------
  ***Age***                                       Mean (SD)       49 (10.7)         56 (12.8)

                                                                                    

  ***Height***                                    Cm (sd)         162.9 (6.61)      161.9 (6.26)

                                                                                    

  ***Weight***                                    Kg (sd)         75.0 (15.66)      72.2 (14.08)

                                                                                    

  ***First language***                            English (%)     109 (98%)         61 (97%)

                                                                                    

                                                  Other EU (%)    0 (0%)            1 (2%)

                                                                                    

                                                  Asian (%)       2 (2%)            0 (0%)

                                                                                    

                                                  Other (%)       0 (0%)            1 (2%)

                                                                                    

  ***Health Status/5***                           Mean (SD)       2.7 (1.07)        2.6 (0.8)

                                                                                    

  ***GP appointments in the last year***          Mean (SD)       1.84 (1.59)       1.56 (1.19)

                                                                                    

  ***Education continued after school***          Yes (%)         61 (55%)          35 (56%)

                                                                                    

                                                  No (%)          50 (45%)          28 (44%)

                                                                                    

  ***Degree or equivalent qualification***        Yes (%)         36 (32%)          25 (40%)

                                                                                    

                                                  No (%)          75 (68%)          38 (60%)

                                                                                    

  ***Employed***                                  Yes (%)         73 (66%)          33 (52%)

                                                                                    

                                                  No (%)          38 (34%)          30 (48%)

                                                                                    

  ***Other limiting illness***                    Yes (%)         36 (32%)          21 (33%)

                                                                                    

  ***Years of living with urinary problem***      Mean (SD)       5.8 (6.44)        6.6 (7.71)

                                                                                    

  ***Previous surgical treatment***               Yes (%)         7 (6%)            7 (11%)

                                                                                    

                                                  No (%)          103 (93%)         56 (89%)

                                                                                    

  ***SSI (0 - 20)***                              Mean (SD)       10.62 (3.96)      10.08 (4.41)

                                                                                    

  ***IQOL (0 - 100)***                            Mean (SD)       58.48 (23.01)     61.27 (21.49)

                                                                                    

  ***Previous physiotherapy treatment***          Yes             10 (9%)           7 (11%)

                                                                                    

                                                  No              101 (91%)         56 (89%)

                                                                                    

  ***Preference for treatment prior to study***   Group           12 (11%)          4 (6%)

                                                                                    

                                                  Individual      38 (34%)          24 (38%)

                                                                                    

                                                  No preference   61 (55%)          35 (55%)
  -------------------------------------------------------------------------------------------------------------

Treatments received
-------------------

Five physiotherapists were involved in delivering the intervention, and gave both individual and group treatments. The median number of treatment sessions was 3 in both the individual and group treatment arms. The uptake of treatment was similar across all sites. Adherence with the clinical protocol was good, with only 4% of women receiving more than 3 treatment sessions in the group arm, and 2% in the individual arm (see Figure [2](#F2){ref-type="fig"} for treatment attendance). Equal numbers of women did not attend treatment in each arm (6%). The average group size was 7, decreasing to 6.4 and 6.3 women at the second and third groups. Treatments received in either arm were almost identical with over 90% of group and individual sessions containing education, advice and pelvic floor exercises. Bladder re-education was a common component of both individual (78%) and group based treatments (70%). Digital examination was used more frequently in the individual group (9.5% versus 4%).

![**Percentage of women randomised who attended 0, 1, 2, 3, 4 and \> 5 sessions by assignment**.](1472-6874-9-26-2){#F2}

Efficacy analysis
-----------------

### Disease specific outcomes

The majority of women reported improvements in the SSI and IQOL over the study period, with no statistically or clinically significant differences between the arms of the trial (Additional file [1](#S1){ref-type="supplementary-material"}).

### Self-rated assessment of treatment benefit

Women in the individual arm reported greater self-rated benefit (data shown in Table [2](#T2){ref-type="table"}).

###### 

Number (and percentage) of women who gained benefit from treatment (ranging from 0 to 10) for the follow-up time-points

                                             **3 months**   **5 months**                  
  ------------------------------------------ -------------- ---------------- ------------ ----------------
  **Benefit gained from treatment (0-10)**   **Group**      **Individual**   **Group**    **Individual**
                                                                                          
  Missing                                    15 (13.5%)     8 (12.7%)        12 (10.8%)   3 (4.8%)
                                                                                          
  0                                          7 (6.3%)       3 (4.8%)         7 (6.3%)     5 (7.9%)
                                                                                          
  1                                          2 (1.8%)       0 (0%)           3 (2.7%)     0 (0%)
                                                                                          
  2                                          7 (6.3%)       1 (1.6%)         3 (2.7%)     3 (4.8%)
                                                                                          
  3                                          16 (14.4%)     3 (4.8%)         13 (11.7%)   2 (3.2%)
                                                                                          
  4                                          9 (8.1%)       5 (7.9%)         7 (6.3%)     3 (4.8%)
                                                                                          
  5                                          15 (13.5%)     11 (17.5%)       21 (18.9%)   9 (14.3%)
                                                                                          
  6                                          10 (9%)        5 (7.9%)         6 (5.4%)     3 (4.8%)
                                                                                          
  7                                          10 (9%)        7 (11.1%)        13 (11.7%)   9 (14.3%)
                                                                                          
  8                                          12 (10.8%)     9 (14.3%)        13 (11.7%)   13 (20.6%)
                                                                                          
  9                                          2 (1.8%)       1 (1.6%)         6 (5.4%)     6 (9.5%)
                                                                                          
  10                                         6 (5.4%)       10 (15.9%)       7 (6.3%)     7 (11.1%)

Preferences
-----------

Just over half of the women (55% in each group) expressed no preference. Of the remainder, the majority expressed a preference for individual treatment and these were near equally allocated to group and individual treatment (Table [1](#T1){ref-type="table"}). Preference was associated weakly with more severe symptoms (measured by the SSI). Women who expressed a preference for group treatment tended toward milder symptoms (χ^2^= 11.65 p \< 0.05). However, using a formal test of interaction, preference was not associated with outcome. Also, preference was not associated with any of the other demographic or baseline characteristics

Cost analysis
-------------

Group treatments cost significantly less (Additional file [2](#S2){ref-type="supplementary-material"}). The average cost to the NHS of the treatments provision was £7.73 per group participant, and £53.37 per participant for individual treatment. When all health care costs were considered (including NHS service costs and patient costs incurred), the average cost per patient was £52.91 (£25.82 to £80.00) lower in the group treatment arm.

Discussion
==========

It is accepted that education, advice, pelvic floor exercises and bladder re-training are essential and effective in the management of stress and urge urinary incontinence in both younger and older women \[[@B17]-[@B19]\]. Other treatments including electrotherapies, biofeedback, vaginal cones offer no substantial advantage over these approaches\[[@B8],[@B18]\] and hence were excluded from both the individual and group treatment arms. By five months symptoms were reduced and incontinence quality of life improved, regardless of the treatment allocation. Responses to treatment in terms of disease specific outcomes were greater in women allocated to the group sessions, although the difference did not reach statistical significance. If left unmanaged, symptoms of incontinence would not resolve spontaneously\[[@B20]\].

The burden of incontinence is well recognised at the population level \[[@B5]\]. Demand for incontinence services is high, and is set to increase substantially due to the combination of population ageing and more women seeking treatment \[[@B5]\]. Significant gains in health related quality of life would occur if effective treatments were both provided to and used by women with incontinence. Group treatments are attractive from the provider perspective, and our study confirms that groups are associated with lower average costs.

Although there was a trend toward greater benefits in terms of health related quality of life in the group sessions, these did not reach statistical significance. This is surprising as lowering psychological burden, which is one of the main components of the IQOL, is one of the postulated mechanisms of group sessions. It is possible that the format of groups was too didactic, and a more interactive approach may have been better.

Being embarrassed about symptoms is a barrier to seeking treatment\[[@B21]\]. Surprisingly, preference for treatments had little association with treatment effectiveness. One explanation is that only a minority of women expressed a preference. Further insight may have been gained by measuring the strength of preference. Women who were randomised against their preference for individual treatment (i.e. to group treatment) were interviewed to ascertain their concerns and to gain insights into improving the acceptability of the service delivery model. These findings are reported in the accompanying manuscript.

Self-rated response to the intervention was somewhat convergent with the disease specific outcomes. This discrepancy is most likely due to the increased and individualised attention that women receiving one to one treatments may have perceived. Attendance at the sessions was similar in both arms of the trial, and further supports the hypothesis that acceptability was equal.

Strengths and Weaknesses of the Study
-------------------------------------

Randomised comparisons of different service delivery models are relatively rare. The sample size was calculated a priori, without accounting for any potential clustering or therapist effects. As the loss to follow up rate was smaller than anticipated, the eventual sample size was 158 patients, giving sufficient power to account for the modest clustering effects observed. We cannot imply equivalence of these two approaches; we were not powered to do so, but can confirm that there was no indication of a substantial and systematic difference between the treatments.

The follow up time period was relatively short, although similar to several trials of physiotherapy\[[@B22]\]. We cannot generalise beyond the 5-month follow up period. Future studies should have longer periods of follow up.

We monitored relative costs using self-reported data using a postal questionnaire. Whilst it was not possible to collect detailed costs that can be ascertained during face-to-face interview\[[@B23]\], the use of questionnaires to determine major costs is recognised as a valid technique \[[@B24]\].

Conclusion
==========

Whilst women or health service providers may have initial reservations about group treatment, there are no substantial differences in the symptom, psychological, or quality of life outcomes. Attendance was very similar between the two arms, allying fears that the groups might intimidate women, and result in non-attendance. Acceptability was explored further to determine how implementation of group treatments might be improved, and is presented in the accompanying paper.

Findings are consistent with our knowledge of the physical effects of physiotherapy for treatment for urinary incontinence\[[@B22]\]. This is the first trial to investigate the claim group treatments may have a psychological effect. The group sessions were no more effective in reducing the burden of psychological symptoms and distress than individual sessions.

Urinary incontinence is a significant public health problem, and group treatments offer one method of offering treatment to large groups of patients. Commissioners and policy makers should feel confident that women will both attend and gain benefit from group sessions.
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